{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:28:30Z","timestamp":1765758510653,"version":"3.37.3"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0191799","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T13:34:05Z","timestamp":1517492045000},"page":"e0191799","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Genotype distribution and treatment response among incarcerated drug-dependent patients with chronic hepatitis C infection"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7262-861X","authenticated-orcid":true,"given":"Chun-Han","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Chung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Tsung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Hsien","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Kai","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Jong","family":"Bair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.26387","article-title":"Incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta-analysis","volume":"58","author":"S Larney","year":"2013","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1097\/01.aids.0000192069.95819.aa","article-title":"Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention","volume":"19","author":"CM Weinbaum","year":"2005","journal-title":"Aids"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2105\/AJPH.94.7.1218","article-title":"Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons","volume":"94","author":"GE Macalino","year":"2004","journal-title":"Am J Public Health"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/hep.25770","article-title":"Comparison of hepatitis C virus treatment between incarcerated and community patients","volume":"56","author":"JP Rice","year":"2012","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1186\/1471-2458-10-633","article-title":"Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort","volume":"10","author":"S Teutsch","year":"2010","journal-title":"BMC Public Health"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1353\/hpu.2011.0084","article-title":"Prevalence of HCV risk behaviors among prison inmates: tattooing and injection drug use","volume":"22","author":"M Pe\u00f1a-Orellana","year":"2011","journal-title":"J Health Care Poor Underserved"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/jmv.21658","article-title":"Molecular epidemiology of HCV genotypes among injection drug users in Taiwan: Full-length sequences of two new subtype 6w strains and a recombinant form_2b6w","volume":"82","author":"YM Lee","year":"2010","journal-title":"J Med Virol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.4254\/wjh.v7.i21.2323","article-title":"Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment","volume":"7","author":"R Zampino","year":"2015","journal-title":"World J Hepatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/add.13783","article-title":"Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland","volume":"112","author":"J Stone","year":"2017","journal-title":"Addiction"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11673-014-9547-y","article-title":"Expert perspectives on Western European prison health services: do ageing prisoners receive equivalent care?","volume":"11","author":"W Bretschneider","year":"2014","journal-title":"J Bioeth Inq"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/jmv.2001","article-title":"Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan","volume":"65","author":"ML Yu","year":"2001","journal-title":"J Med Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.trstmh.2005.10.008","article-title":"Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications","volume":"100","author":"CM Lee","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1017\/S0950268806006820","article-title":"Prevalence of hepatitis C in a German prison for young men in relation to country of birth","volume":"135","author":"MF Meyer","year":"2007","journal-title":"Epidemiol Infect"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e14559","DOI":"10.5812\/hepatmon.14559","article-title":"Distribution of HCV genotypes in the populations of inmates in polish prison Potulice and patients hospitalised in Bydgoszcz","volume":"14","author":"M Tyczyno","year":"2014","journal-title":"Hepat Mon"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e94791","DOI":"10.1371\/journal.pone.0094791","article-title":"Hepatitis C virus infection among injection drug users with and without human immunodeficiency virus co-infection","volume":"9","author":"MH Hsieh","year":"2014","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s10620-008-0483-8","article-title":"Access to treatment of hepatitis C in prison inmates","volume":"54","author":"P Strock","year":"2009","journal-title":"Dig Dis Sci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1572-0241.2004.30310.x","article-title":"Treatment of chronic hepatitis C virus in the virginia department of corrections: can compliance overcome racial differences to response?","volume":"99","author":"RK Sterling","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2105\/AJPH.2004.056150","article-title":"Feasibility and outcome of HCV treatment in a Canadian federal prison population","volume":"95","author":"J Farley","year":"2005","journal-title":"Am J Public Health"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/MCG.0b013e31818dd94c","article-title":"Treatment outcomes with pegylated interferon and ribavirin for male prisoners with chronic hepatitis C","volume":"43","author":"KW Chew","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/1471-2334-13-374","article-title":"HCV infected prisoners: should they be still considered a difficult to treat population?","volume":"13","author":"F Iacomi","year":"2013","journal-title":"BMC Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.dld.2010.12.004","article-title":"Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates)","volume":"43","author":"PL Almasio","year":"2011","journal-title":"Dig Liver Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"762","DOI":"10.7326\/0003-4819-144-10-200605160-00010","article-title":"A framework for management of hepatitis C in prisons","volume":"144","author":"AC Spaulding","year":"2006","journal-title":"Ann Intern Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.kjms.2015.09.006","article-title":"The genotype distribution of hepatitis C in southeastern Taiwan: Clinical characteristics, racial difference, and therapeutic response","volume":"31","author":"CH Cheng","year":"2015","journal-title":"Kaohsiung J Med Sci"},{"issue":"Suppl 2","key":"ref24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1478-3231.2011.02540.x","article-title":"A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt","volume":"31","author":"W Sievert","year":"2011","journal-title":"Liver Int"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.3748\/wjg.v20.i11.2927","article-title":"Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication","volume":"20","author":"VD Thong","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1086\/587992","article-title":"Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan","volume":"46","author":"JY Liu","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.5694\/j.1326-5377.2010.tb03605.x","article-title":"Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C","volume":"192","author":"L Boonwaat","year":"2010","journal-title":"Med J Aust"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7326\/0003-4819-138-3-200302040-00010","article-title":"Treatment of chronic hepatitis C in a state correctional facility","volume":"138","author":"SA Allen","year":"2003","journal-title":"Ann Intern Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"MW Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"MP Manns","year":"2001","journal-title":"Lancet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2013.03.008","article-title":"Hepatitis C virus reinfection among prisoners with sustained virological response after treatment for chronic hepatitis C","volume":"59","author":"A Marco","year":"2013","journal-title":"J Hepatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"288","DOI":"10.7326\/0003-4819-136-4-200202190-00008","article-title":"Surprisingly small effect of antiviral treatment in patients with hepatitis C","volume":"136","author":"Y Falck-Ytter","year":"2002","journal-title":"Ann Intern Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1006\/pmed.1998.0418","article-title":"Hepatitis C in state correctional facilities","volume":"28","author":"A Spaulding","year":"1999","journal-title":"Prev Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.22509","article-title":"Treating hepatitis C in the prison population is cost-saving","volume":"48","author":"JA Tan","year":"2008","journal-title":"Hepatology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.kjms.2017.06.005","article-title":"High frequencies of a favorable IL-28B rs8099917 polymorphism and the clinical implications in patients with HCV in one multiracial area of Taiwan","volume":"33","author":"CH Cheng","year":"2017","journal-title":"Kaohsiung J Med Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0191799","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:33:59Z","timestamp":1570667639000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0191799"}},"subtitle":[],"editor":[{"given":"Chen-Hua","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,2,1]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0191799","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,2,1]]}}}